Burden of Chronic Health Conditions Increased for LGTBQ+ Cancer Survivors

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, June 20, 2024 -- Cancer survivors who identify as lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) have an increased burden of all chronic health conditions, disabilities, and limitations, according to a study published online June 20 in Cancer Epidemiology, Biomarkers & Prevention.

Austin R. Waters, from the University of North Carolina at Chapel Hill, and colleagues used pooled, weighted Behavioral Risk Factor Surveillance System data from 23 states that completed two specific modules from 2020 to 2022 to examine the risk for chronic health conditions and physical and cognitive limitations in LGBTQ+, LGB, transgender or gender-nonconforming (TGNC), and non-LGBTQ+ cancer survivors. Overall, 1,715 of the 40,990 cancer survivors were LGBTQ+.

The researchers found that the age-adjusted prevalence of all outcomes was significantly higher for LGBTQ+ survivors. TGNC survivors had the highest prevalence of all outcomes apart from depressive disorders and cognitive limitations. Higher odds of reporting asthma, depressive disorders, kidney disease, stroke, diabetes, vision disability, cognitive limitations, difficulty walking, dressing, and running errands was seen for LGBTQ+ survivors. TGNC cancer survivors had increased odds of the most outcomes in multivariable models run to compare TGNC survivors with non-TGNC survivors.

"Our findings reinforce the need for multilevel interventional approaches, from structural changes to patient-level to mitigate health disparities experienced by LGBTQ+ cancer survivors," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-21 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords